Spero Therapeutics, Inc.【SPRO】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -473,500 +17.3%
4Q24 -459,600 +17.5%
3Q24 -438,800 -0.8%
2Q24 -421,600 -4.0%
1Q24 -403,700 -5.5%
4Q23 -391,100 -5.5%
3Q23 -442,300 +0.4%
2Q23 -439,100 +2.4%
1Q23 -427,100 +6.7%
4Q22 -413,900 +12.6%
3Q22 -440,600 +30.3%
2Q22 -429,000 +35.9%
1Q22 -400,300 +34.7%
4Q21 -367,500 +32.3%
3Q21 -338,200 +30.5%
2Q21 -315,700 +31.4%
1Q21 -297,100 +33.4%
4Q20 -277,707 +39.3%
3Q20 -259,122 +48.5%
2Q20 -240,186 +53.3%
1Q20 -222,685 +55.1%
4Q19 -199,427 +44.0%
3Q19 -174,441 +36.4%
2Q19 -156,724 +33.5%
1Q19 -143,574 +33.6%
4Q18 -138,502 +43.0%
3Q18 -127,903 +55.6%
2Q18 -117,440 -
1Q18 -107,484 -
4Q17 -96,840 -
3Q17 -82,194 -